WallStSmart

Coherent Inc (COHR)vsNovanta Inc (NOVT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coherent Inc generates 557% more annual revenue ($6.60B vs $1.00B). COHR leads profitability with a 7.1% profit margin vs 5.3%. COHR appears more attractively valued with a PEG of 0.92. COHR earns a higher WallStSmart Score of 56/100 (C).

COHR

Buy

56

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 5.0Quality: 7.5
Piotroski: 5/9Altman Z: 1.53

NOVT

Hold

44

out of 100

Grade: D

Growth: 4.0Profit: 5.0Value: 2.7Quality: 8.0
Piotroski: 3/9Altman Z: 2.94
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for COHR.

NOVTSignificantly Overvalued (-35.1%)

Margin of Safety

-35.1%

Fair Value

$105.01

Current Price

$137.77

$32.76 premium

UndervaluedFair: $105.01Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COHR4 strengths · Avg: 8.8/10
EPS GrowthGrowth
73.0%10/10

Earnings expanding 73.0% YoY

Market CapQuality
$61.08B9/10

Large-cap with strong market position

PEG RatioValuation
0.928/10

Growing faster than its price suggests

Revenue GrowthGrowth
20.5%8/10

Revenue surging 20.5% year-over-year

NOVT1 strengths · Avg: 9.0/10
Debt/EquityHealth
0.229/10

Conservative balance sheet, low leverage

Areas to Watch

COHR4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Return on EquityProfitability
4.4%3/10

ROE of 4.4% — below average capital efficiency

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

P/E RatioValuation
149.4x2/10

Premium valuation, high expectations priced in

NOVT4 concerns · Avg: 3.3/10
PEG RatioValuation
2.114/10

Expensive relative to growth rate

Return on EquityProfitability
5.2%3/10

ROE of 5.2% — below average capital efficiency

Profit MarginProfitability
5.3%3/10

5.3% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : COHR

The strongest argument for COHR centers on EPS Growth, Market Cap, PEG Ratio. Revenue growth of 20.5% demonstrates continued momentum. PEG of 0.92 suggests the stock is reasonably priced for its growth.

Bull Case : NOVT

The strongest argument for NOVT centers on Debt/Equity. Revenue growth of 10.4% demonstrates continued momentum.

Bear Case : COHR

The primary concerns for COHR are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 149.4x leaves little room for execution misses.

Bear Case : NOVT

The primary concerns for NOVT are PEG Ratio, Return on Equity, Profit Margin. A P/E of 102.5x leaves little room for execution misses.

Key Dynamics to Monitor

COHR profiles as a growth stock while NOVT is a value play — different risk/reward profiles.

COHR carries more volatility with a beta of 2.04 — expect wider price swings.

COHR is growing revenue faster at 20.5% — sustainability is the question.

NOVT generates stronger free cash flow (46M), providing more financial flexibility.

Bottom Line

COHR scores higher overall (56/100 vs 44/100) and 20.5% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coherent Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a variety of scientific, commercial, and industrial research applications. The company is headquartered in Santa Clara, California.

Novanta Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.

Want to dig deeper into these stocks?